Medtronic Completes Acquisition of CathWorks for $585 Million
Medtronic has completed its $585 million acquisition of CathWorks, a company specializing in coronary artery disease diagnostics and treatment. The acquisition expands Medtronic's cardiovascular product portfolio and follows a strategic partnership since 2022. The deal is expected to have minimal impact on 2027 earnings but may become accretive in subsequent years.
Tickers: $MDT
Topics: AI in Medicine Cardiovascular Disease Healthcare Technology Mergers and Acquisitions